Samyukta Mullangi, MD, MBA, oncology fellow at Memorial Sloan Kettering Cancer Center and incoming medical director at Thyme Care, explained Thyme Care’s value-based care (VBC) system in oncology and the benefits of care navigation.
Thyme Care’s proprietary tech platform combines navigation software with analytics to ensure equitable care delivery at scale, and conducts contracting directly with payers via risk sharing contracts to align value-based care (VBC) incentives, said Samyukta Mullangi, MD, MBA, oncology fellow at Memorial Sloan Kettering Cancer Center and incoming medical director at Thyme Care.
Transcript
Can you explain how Thyme Care’s VBC systems differ from traditional models, particularly in addressing structural barriers within cancer care?
Thyme Care is an oncology population management platform with a core product that delivers care navigation to patients with cancer. Care navigation has been shown in a variety of studies to improve patient outcomes on a variety of metrics, including symptom management, care coordination, medication adherence, and ultimately reducing cost.
There have been a fair number of studies that have shown a positive return on investment for patients enrolled in health systems that operate both in fee-for-service environments, as well as those that participate in alternative payment models. So, I would say that care navigation does not really require more evidence to show that it works. It can help patients maneuver through a complex and fragmented care delivery system, and I would say this is particularly important in cancer.
But despite the plethora of evidence showing benefit, the vast majority of patient navigation systems are perceived as financially taxing to a practice or a health system, and are often condemned to remain in pilot mode, reliant on grants or one off sources of funding. And the question is, why is this? Why do good evidence-based delivery system innovations not scale?
The [perception] is that cancer navigation works, but isn't widely available because it's hard to scale and incentives are hard to align. So, Thyme Care solves both. It solves the former through its proprietary tech platform, which combines navigation software with analytics. Navigation is able to scale when you have the ability to intelligently triage patients by their acuity level so that you're delivering the right dose of navigation to the right patient at the right time.
The platform is sophisticated enough to allow multiple team members to effectively and efficiently collaborate on the care of a single patient thereby extending their reach, but simultaneously reducing their administrative burden. It solves the problem about misaligned incentives by contracting directly with payers via risk sharing contracts, and also fostering deep partnerships with providers.
Thyme Care is still an early-stage company, but even within its short run, it's already proven that its model can yield cost savings for payers. And I'm hopeful that this track record will overcome some of that inertia or hesitancy that payers have in investing in programs that have upfront costs with the hope of downstream savings. I've been really impressed by Thyme Care’s mission-oriented leadership, and I believe that they really built this company with an eye towards driving value to patients.
Despite Record ACA Enrollment, Report Reveals Underinsured Americans are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access and affordability to health care.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Surgeon General Calls for Action on Tobacco Use, Outcomes Disparities
November 19th 2024The new report from US Surgeon General Vivek H. Murthy, MD, MBA, highlights persistent disparities in tobacco use and secondhand smoke exposure, calling for equitable strategies to achieve a tobacco-free future.
Read More
Racial Inequities in Guideline-Adherent Breast Cancer Care and Timely Treatment
November 19th 2024Older non-Hispanic Black adults with early-stage breast cancer are less likely to receive timely treatment and guideline-concordant care, increasing their risk of death compared with non-Hispanic White women.
Read More
Despite Record ACA Enrollment, Report Reveals Underinsured Americans are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access and affordability to health care.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Surgeon General Calls for Action on Tobacco Use, Outcomes Disparities
November 19th 2024The new report from US Surgeon General Vivek H. Murthy, MD, MBA, highlights persistent disparities in tobacco use and secondhand smoke exposure, calling for equitable strategies to achieve a tobacco-free future.
Read More
Racial Inequities in Guideline-Adherent Breast Cancer Care and Timely Treatment
November 19th 2024Older non-Hispanic Black adults with early-stage breast cancer are less likely to receive timely treatment and guideline-concordant care, increasing their risk of death compared with non-Hispanic White women.
Read More
2 Commerce Drive
Cranbury, NJ 08512